Ethicon Inc Archives - Carey Danis & Lowe

TVM Dallas Case

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

Anterior-Vaginal-MeshEthicon, a branch of Johnson & Johnson, failed to disclose the dangers and complications linked to its Prosima vaginal mesh device. These statements were given by experts in Texas State Court in late September.

In the first court case involving Ethicon Inc.’s Prosima product, Dallas County District Court jurors were presented internal Ethicon documents that U.S. FDA specialists and urogynecology experts said showed the company was aware the product showed more risks and potential problems than Ethicon told doctors about.

By not disclosing the vaginal mesh risks, Ethicon is to blame for her pain and suffering, says Plaintiff Carol Cavness.

In heart-wrenching testimony, Ms. Cavness told the court how the agony and limitations caused by the Prosima vaginal mesh device affected her marriage to the point of divorce. The Prosima complications also continue to hinder her relationships with her children and grandchildren because she’s no longer physically able to join in activities with them.

In addition, Carol Cavness fears losing her airline mechanic job because the physical pain impairs her ability to perform heavy physical duties required by the job.

Three of the 6 cases filed against Ethicon over its pelvic mesh products have returned jury awards ranging from $1.2 to $11.1 million.

Carey Danis & Lowe seeks justice in medical product liability cases.

If you or a loved one has suffered complications related to the vaginal mesh Prosima device, compensation for pain and suffering may be due.

Our expert product liability attorneys will guide you through a free consultation and give you details about filing a Prosima mesh lawsuit.

Please contact Carey Danis & Lowe by calling 800.721.2519 or send us an email.

Transvaginal Mesh Lawsuit Update: West Virginia MDLs Met Mid-September for Status Conference

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

transvaginal_mesh_lawsuit_settlements_news_mdl_class_action_lawsuit_vaginal_mesh_lawsuit_erosion_pain_bleedingThere are six transvaginal mesh multidistrict litigations (MDLs) being heard by U.S. District Judge Joseph R. Goodwin in the U.S. District Court for the Southern District of West Virginia. The court convened in mid-September for a status conference to discuss progress in all six of the transvaginal mesh MDLs.

Both parties discussed the deadline for filing transvaginal mesh lawsuits. Judge Goodwin stated that he would mull over a deadline extension and flexibility on the weekly filing allowance.

The plaintiffs counsel and defendants counsel also discussed progress being made in the bellwether trial process. According to the status conference minutes, the next bellwether trial among the six transvaginal mesh MDLs will be Jones v. C. R. Bard, scheduled to begin on November 12, 2013.

In the American Medical Systems MDL, the first bellwether trial was scheduled for December 2013, but has been delayed with a new start date yet to be decided.

The six transvaginal mesh MDLs are:

  • In re: C. R. Bard, Inc., Pelvic Repair System Products Liability Litigation MDL No. 2187
  • In re: American Medical Systems, Inc., Pelvic Repair System Products Liability Litigation MDL No. 2325
  • In re: Boston Scientific Corp., Pelvic Repair System Products Liability Litigation MDL No. 2326
  • In re: Ethicon Inc., Pelvic Repair System Products Liability Litigation MDL No. 2327
  • In re: Coloplast Corp. Pelvic Support Systems Products Liability Litigation MDL No. 2387
  • In re: Cook Medical, Inc., Pelvic Repair System Products Liability Litigation MDL No. 2440

According to the U.S. Food and Drug Administration (FDA), patients who experienced an adverse effect from transvaginal mesh most often reported mesh erosion as being the complication. Transvaginal mesh erosion occurs when the mesh begins eroding surrounding tissue and organs. The FDA has also reviewed a number of adverse event reports wherein the patient experienced infection, bleeding, and painful intercourse associated with a transvaginal mesh implant.

The team of St. Louis class action attorneys at Carey Danis & Lowe work diligently to win you or your loved one a day in court, so that your transvaginal mesh case can finally be heard. Work with one of our transvaginal mesh lawyers, and receive a free legal evaluation of your transvaginal mesh case. Carey Danis & Lowe can also assist with evaluating your compensation eligibility and with filing a transvaginal mesh lawsuit.

Share your story with Carey Danis & Lowe by calling 800.721.2519, or by submitting a personal injury claim form.

Update on Defective Transvaginal Mesh MDLs in U.S. District Court in West Virginia

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

Update on Defective Transvaginal Mesh MDLs in U.S. District Court in West VirginiaLawsuits involving transvaginal mesh and other surgical implants used to treat stress urinary incontinence (SUI) or pelvic organ prolapse (POP) have been consolidated into five individual Multi-District Litigation (MDL) cases in the U.S. District Court for the Southern District of West Virginia, overseen by Chief Judge  Joseph R. Goodwin.

The MDLs involve lawsuits that have been filed against C.R. Bard, Inc., American Medical Systems, Inc., Boston Scientific Corporation, Ethicon Inc., and Coloplast Corp.

Parties were convened for a Status Conference Hearing on December 6, 2012, with the next Status Conference for these five MDLs is scheduled for January 10, 2013.

During the Status Conference on December 6, there was discussion about the content of the first of the bellwether trials.

The legal representatives for the defendants made a statement that the first case to go on trial should be one pertaining to stress urinary incontinence (SUI), as lawsuits regarding SUI and surgical implants of transvaginal mesh make up a large majority of cases in the MDLs.

Providing further insight on this topic of SUI cases and POP cases, Chief Judge Goodwin recognized the difficulty of bellwether trials that involve several manufacturers and several products in a single case. Chief Judge Goodwin made a statement indicating his dislike for these cases, and how in choosing cases for the bellwether trials, he will refrain from selecting those that are multi-manufacturer and multi-product.

The defendants and the plaintiffs legal counsel will begin developing discovery pools and trial pools, and during this process, they will be carefully examining each case to determine if it is representative of a majority of the cases consolidated into each of the five MDLs. It was brought up by the plaintiffs’ legal counsel that finding cases that are single product cases pertaining to only SUI or only POP will be difficult, as most cases filed with the court are a combination.

Before the court adjourned, Chief Judge Goodwin acknowledged the great number of lawsuits going to trial in 2013 regarding defective transvaginal mesh products. Chief Judge Goodwin recognized the importance of following these trials.

The first bellwether trial is set for December 3, 2013, and Chief Judge Goodwin has ordered that two trials be prepared for December 3, so that the bellwether process is efficient.

Patients who have received a surgical implant of defective transvaginal mesh, vaginal slings, and vaginal tape to treat SUI or POP have experienced an enormous amount of pain and suffering, including:

  • infection
  • severe pain in the pelvic region
  • bleeding
  • pain during intercourse
  • vaginal erosion
  • organ perforation
  • revision surgery

If you or a loved one has received a surgical implant of defective transvaginal mesh, a defective vaginal sling, or defective vaginal tape, you and your loved one may be entitled to receive recompense for your medical expenses, emotional suffering, and other hardships.

For a free legal consultation about your vaginal mesh case, contact a lawyer at Carey Danis & Lowe to learn more about how to file a vaginal mesh lawsuit. Get legal help today by calling a lawyer at Carey Danis & Lowe at 800.721.2519.

Johnson & Johnson Stops Sales of Gynecare Transvaginal Mesh

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

In June 2012, Johnson & Johnson made the decision to remove their defective transvaginal mesh (TVM) medical device from the global market. Though the medical device manufacturer cites future market performance as being the reason for the discontinuation of sales, their decision comes as there is an ever-increasing number of lawsuits citing links between their transvaginal mesh devices and severe health complications.

According to a Reuters report from June 2012, there are currently over 1,000 transvaginal mesh lawsuits  filed against Ethicon Inc., the subsidiary of Johnson & Johnson responsible for the manufacture of the defective transvaginal mesh. The Johnson & Johnson Gynecare vaginal mesh lawsuits are being heard by a federal judge in West Virginia and a state judge in New Jersey.

As a result of surgical implantation of Johnson & Johnson’s Gynecare Prolift transvaginal mesh devices, patients have claimed organ injury, bleeding, infections, and severe pain. Transvaginal mesh is used to treat women suffering from pelvic organ prolapse or stress urinary incontinence, both health conditions resulting from muscle weakening in the pelvic region.

According to a statement made by an Ethicon spokesperson, the medical device manufacturer has made a plan to pull several Gynecare products from the global market, including the Gynecare TVT Secur, Gynecare Prosima, Gynecare Prolift, and Gynecare Prolift+M, all transvaginal mesh devices.

Back in January 2012, the U.S. Food and Drug Administration ordered transvaginal mesh manufacturers, such as Ethicon and Johnson & Johnson, to begin studying patients with surgically implanted transvaginal mesh to better understand the safety of such products. As Johnson & Johnson has made the decision to pull four of their surgical mesh devices from the global market, the company has stated that it should no longer have to conduct studies of patients with their surgical mesh implants.

If you or someone you love has undergone surgery to receive one of the discontinued Johnson & Johnson transvaginal mesh devices, and as a result, has suffered enormously from physical pain and financial losses, you and your loved one may be entitled to receive compensation. For a free legal consultation about your Johnson & Johnson Gynecare transvaginal mesh case, contact an experienced defective medical device lawyer at Carey Danis & Lowe today by calling 800.721.2519.

Transvaginal Mesh Safety Information Disclosure & Transvaginal Mesh MDL Grows Larger

By | Defective Medical Device litigation, Transvaginal Mesh, Uncategorized

Published September 11, 2012 on Carey & Danis

Transvaginal Mesh Safety Information Disclosure & Transvaginal Mesh MDL Grows LargerA manufacturer of transvaginal mesh products has recently been ordered in a vaginal mesh federal lawsuit to fully supply the safety information it imparted to the U.S. Food and Drug Administration (FDA) for the purpose of gathering whether the medical device manufacturer withheld any integral pieces of data regarding negative impacts on health from use of its transvaginal mesh product.

A superior court judge in New Jersey made the request of the transvaginal mesh manufacturer, Ethicon Inc., that it release documents on the subject of its clinical trial data and safety observations of its Gynecare transvaginal mesh products. In a report by Bloomberg news, it is understood that the FDA in 2007 mandated that, as adequate safety information was never recorded in regards to Ethicon’s Gynecare transvaginal mesh products, the medical device manufacturer remove such products from the market.

According to the Bloomberg report, Ethicon continued to sell its Gynecare transvaginal mesh products to patients in spite of the FDA mandate. Apparently, the total dismissal of such an FDA mandate is considered a violation of the Federal Food, Drug, and Cosmetic Act. Ethicon reported that, without receiving official FDA approval, they could market and sell the Gynecare transvaginal mesh products because they had received prior FDA approval on a similar transvaginal mesh product. The release of the Gynecare transvaginal mesh line has been referred to as a fast tracking process, one that eliminates the important safety checks via the FDA.

In a multidistrict litigation (MDL), presided over by Judge Joseph R. Goodwin in the U.S. District Court for the Southern Court of Virginia, it has been reported by a Drugwatch journalist that two Arkansas residents have filed a transvaginal mesh lawsuit against medical device manufacturer Boston Scientific Center. The Arkansas couple’s lawsuit makes the claim that Boston Scientific Center developed a transvaginal mesh product made out of materials that cause painful internal tissue inflammation.

Boston Scientific Center’s transvaginal mesh product under question is made out of a monofilament polypropylene that, according to the plaintiff, was known by the manufacturer to cause tissue damage. However, despite such knowledge, the medical device manufacturer made the decision to dismiss such important safety information in order to place the transvaginal mesh product on the market. In the plaintiff’s words, she has suffered enormously from receiving an implantation of Boston Scientific Center’s transvaginal mesh.

Transvaginal mesh is a medical device used as a reinforcing structure, and is especially useful in cases where a patient’s vaginal wall tissues can no longer support surrounding organs. In theory, the surgical implantation of transvaginal mesh should alter a patient’s life for the better, but such is often not the case due to medical device manufacturers releasing products onto the market that are understood to cause severe harm when surgically implanted.